◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

ROCK CREEK PHARMACEUTICALS, INC.

CIK: 776008 SIC: 2833
-
Revenue
$-11.15M
Net Income
-
Gross Margin
-
Op. Margin
-
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 5 annual reports available (2011 - 2015)
Breakdown TTM
(Jun 30, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
+ Total Revenue - - - $9.14M $6.19M $1.24M
Revenue Growth % nan% nan% -100.0% 47.7% 397.4% nan%
Cost of Revenue - - - $5.17M $3.57M $1.86M
+ Gross Profit - - - $3.97M $2.62M $-617.00K
Gross Margin % nan% nan% nan% 43.4% 42.4% -49.6%
Operating Expenses $8.86M $11.31M $32.58M $36.89M $27.23M $35.05M
Research & Development $1.88M $2.48M $3.61M $3.00M $4.56M $3.21M
+ Operating Income $-8.86M $-11.31M $-32.58M $-32.92M $-24.61M $-35.67M
Operating Margin % nan% nan% nan% -360.2% -397.8% -2867.4%
Interest Expense $2.54M $410.00K $1.00K - $104.00K $263.00K
Interest Income - $1.00K $22.00K $14.00K $17.00K $46.00K
Other Income/Expense $124.00K $3.60M $-558.00K $-320.00K $6.60M $-222.00K
Income Before Tax - $-6.76M $-33.12M $-33.23M $-18.10M $-35.89M
Income Tax Expense - - - - - -
+ Net Income $-11.15M $-6.84M $-38.52M $-32.83M $-22.85M $-37.99M
Net Margin % nan% nan% nan% -359.2% -369.3% -3053.7%
Breakdown FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Cash & Cash Equivalents $493.00K $395.00K $3.88M $23.12M $10.19M
Accounts Receivable - - - - $39.00K
Inventory - - $3.47M $4.99M $2.45M
Other Current Assets $485.00K $721.00K $1.57M $1.09M $737.00K
Total Current Assets $1.04M $7.80M $9.01M $29.28M $13.73M
Property Plant & Equipment $170.00K $207.00K $399.00K $1.34M $1.61M
Intangible Assets $55.00K $402.00K $472.00K $541.00K $578.00K
Total Assets $19.55M $8.92M $10.95M $31.92M $17.08M
Accrued Liabilities $3.88M $8.93M $1.81M $2.72M $640.00K
Total Current Liabilities $22.19M $19.40M $3.97M $6.94M $5.16M
Long-term Debt $8.00M $350.00K - - $2.53M
Total Liabilities $30.19M $19.75M $3.97M $6.94M $7.69M
Common Stock $1.00K $19.00K $17.00K $17.00K $14.00K
Retained Earnings $-309.94M $-302.88M $-264.37M $-231.53M $-208.68M
Total Stockholders Equity $-10.65M $-10.84M $6.98M $24.98M $9.39M
Total Liabilities & Equity $19.55M $8.92M $10.95M $31.92M $17.08M
Breakdown TTM
(Jun 30, 2016)
FY 2015
(Dec 31, 2015)
FY 2014
(Dec 31, 2014)
FY 2013
(Dec 31, 2013)
FY 2012
(Dec 31, 2012)
FY 2011
(Dec 31, 2011)
Net Income $-13.84M $-6.84M $-38.52M $-32.83M $-22.85M $-37.99M
Depreciation & Amortization $188.00K $146.00K $92.00K $317.00K $332.00K $195.00K
Stock-based Compensation $1.06M $960.00K $9.64M $7.00M $3.56M $17.26M
Change in Receivables - - - - $-2.00K $2.00K
Change in Inventory - - - $-1.20M $2.71M $198.00K
Operating Cash Flow - - $-16.48M $-26.00M $-17.70M $-17.52M
Capital Expenditure $8.00K $8.00K $218.00K - $19.00K $65.00K
Investing Cash Flow - - $-158.00K $39.00K $-21.00K $-471.00K
Financing Cash Flow - - $14.49M $7.82M $32.17M $16.94M
Net Change in Cash $-151.00K $98.00K $-3.49M $-19.24M $12.93M $-3.00M
SEC Filing Format - Data shown as it appears in the Q2 2016 (10-Q) filing Period ended: Jun 30, 2016
Condensed Consolidated Statements of Operations
Description Jun 30, 2016 Jun 30, 2016
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $2.02M $2.02M $3.38M $5.84M
Research & Development $113.00K $376.00K $245.00K $850.00K
Operating Income $-2.02M $-2.02M $-3.38M $-5.84M
Interest Expense $793.00K - $2.13M -
Other Income/Expense $21.00K $-13.00K $32.00K $3.51M
Net Income $-2.79M $-843.00K $-5.49M $-1.18M
Condensed Consolidated Balance Sheets
Description Jun 30, 2016 Dec 31, 2015
Cash & Cash Equivalents $185.00K $493.00K
Other Current Assets $9.00K $485.00K
Total Current Assets $194.00K $1.04M
Property Plant & Equipment $147.00K $170.00K
Intangible Assets $50.00K $55.00K
Total Assets $11.78M $19.07M
Accrued Liabilities $4.19M $3.88M
Total Current Liabilities $22.02M $22.19M
Long-term Debt $2.74M $7.52M
Total Liabilities $24.77M $29.71M
Common Stock $15.00K $1.00K
Retained Earnings $-315.42M $-309.94M
Total Stockholders Equity $-12.99M $-10.65M
Total Liabilities & Equity $11.78M $19.07M
Condensed Consolidated Statements of Cash Flows
Description Jun 30, 2016 Jun 30, 2016
Current Prior Year Current YTD Prior Year YTD
Net Income $-2.79M $-843.00K $-5.49M $-1.18M
Depreciation & Amortization - - $28.00K $58.00K
Stock-based Compensation - - $67.00K $539.00K
Capital Expenditure - - - $8.00K
Debt Repayment - - $3.00M -
Net Change in Cash - - $-308.00K $2.60M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...